Terms: = Breast cancer AND MKL1, BSAC, 57591, ENSG00000196588, Q969V6, MRTF-A AND Treatment
5 results:
1. MKL-1 suppresses ferroptosis by activating system Xc- and increasing glutathione synthesis.
Dai ZT; Wu YL; Li XR; Liao XH
Int J Biol Sci; 2023; 19(14):4457-4475. PubMed ID: 37781038
[TBL] [Abstract] [Full Text] [Related]
2. miR-142-5p Inhibits Cell Invasion and Migration by Targeting DNMT1 in breast cancer.
Li H; Li HH; Chen Q; Wang YY; Fan CC; Duan YY; Huang Y; Zhang HM; Li JP; Zhang XY; Xiang Y; Gu CJ; Wang L; Liao XH; Zhang TC
Oncol Res; 2022 Jan; 28(9):885-897. PubMed ID: 34321149
[TBL] [Abstract] [Full Text] [Related]
3. Mechanism of irradiation-induced mammary cancer metastasis: A role for SAP-dependent mkl1 signaling.
Asparuhova MB; Secondini C; Rüegg C; Chiquet-Ehrismann R
Mol Oncol; 2015 Oct; 9(8):1510-27. PubMed ID: 25999144
[TBL] [Abstract] [Full Text] [Related]
4. Activation of the mkl1/actin signaling pathway induces hormonal escape in estrogen-responsive breast cancer cell lines.
Kerdivel G; Boudot A; Habauzit D; Percevault F; Demay F; Pakdel F; Flouriot G
Mol Cell Endocrinol; 2014 Jun; 390(1-2):34-44. PubMed ID: 24721635
[TBL] [Abstract] [Full Text] [Related]
5. Tranilast treatment decreases cell growth, migration and inhibits colony formation of human breast cancer cells.
Subramaniam V; Ace O; Prud'homme GJ; Jothy S
Exp Mol Pathol; 2011 Feb; 90(1):116-22. PubMed ID: 21040720
[TBL] [Abstract] [Full Text] [Related]
